Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Febuxostat

144060-53-7C16H16N2O3S316.382 g/mol

A 1,3-thiazolemonocarboxylic acid that is 4-methyl-1,3-thiazole-5-carboxylic acid which is substituted by a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally-active, potent, and selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricaemia in patients with gout. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number144060-53-7ChEBI ↗
Molecular formulaC16H16N2O3SChEBI ↗
Molar mass316.382 g/molChEBI ↗
Monoisotopic mass316.08816 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:31596ChEBI ↗

Cross-source molecular data

PubChem
Molar mass316.4 g/molPubChem ↗
Exact mass316.08816355 DaPubChem ↗
Computed XLogP3.9PubChem ↗
Topological polar surface area (Ų)111PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors6PubChem ↗
Rotatable bonds5PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
febuxostat
2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
BQSJTQLCZDPROO-UHFFFAOYSA-N
Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O
InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)

Names & synonyms

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acidAdenuricDonifoxateFebudayFeburicfebuxostatumGoturicGoutexUloricZurig

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

renoprotective agentcardiovascular drugEC 1.17.3.2 (xanthine oxidase) inhibitorantihypertensive agentgout suppressant

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00316074 mol

Uses 316.382 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 16 atoms
60.74%
O
Oxygen · 3 atoms
15.17%
S
Sulfur · 1 atom
10.14%
N
Nitrogen · 2 atoms
8.85%
H
Hydrogen · 16 atoms
5.10%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:31596

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 134018 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.